Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.
about
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal LiteratureCannabinoid and opioid interactions: implications for opiate dependence and withdrawalCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersRegulation of nausea and vomiting by cannabinoids and the endocannabinoid systemEndocannabinoid signaling in the etiology and treatment of major depressive illness.High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Increased expression of cannabinoid CB₁ receptors in Achilles tendinosis.Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat.Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortexGi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.Biological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemUltrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons.Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal graySafety of oral dronabinol during opioid withdrawal in humansDrug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation.Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.Contribution of limbic norepinephrine to cannabinoid-induced aversion.Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans.Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats.Changes in Gene Expression in the Locus Coeruleus-Amygdala Circuitry in Inhibitory Avoidance PTSD Model.Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study.Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.Emerging Evidence for Cannabis' Role in Opioid Use Disorder
P2860
Q26738333-D8EF6B08-B8C1-4BD0-95C7-8FEAC9D92C5DQ27000762-CD388C2E-09B1-40A6-936D-9DA06E785A9AQ27001139-5152FD00-33DF-48C7-BFE7-A5B5A3A5A718Q28301264-6A37FB28-2D0D-4FB4-9EF7-22D44B467E17Q30687668-4E70423E-35D5-4561-97AE-10679C82CDDAQ34013690-8DC01692-0832-44EE-883E-4EBB3B79F2BFQ34023999-F85DAF63-9E95-49BB-AED8-9549BC7C5D12Q34367943-19DC03D9-526B-47D4-998E-60389B42C43AQ34381331-2BBA971A-FAE1-41C1-A18D-2180C68E9AA4Q34701089-BE6F7FDC-DFA6-4D2C-A0BE-7E4FF8AD3C92Q34973799-61A5CD7B-D781-40C2-B8BF-DD3E4BE45125Q35265686-67194A40-84DF-418F-87A1-3E337220EE31Q35310056-941D9AD7-AA5D-4FF7-BF74-30605ED74A99Q35571722-5FDDB244-ACE6-469A-972A-746014CE7F70Q35971498-13240B03-0163-43D3-9AC9-980F83DBE7E4Q35972392-C29DD6B8-94AC-4414-B4D3-134F9ED55B91Q36007619-30B29417-7636-421D-9FC7-AB92ED54C8ABQ36328458-E874685A-91D9-44F7-A7A9-26785AD25D9CQ36417706-4B7AD803-6ABB-4558-83D9-68E03AE8630AQ37258625-A05FBFAF-6DB7-4FE8-AAF8-ED2CCAEA55A1Q38597060-31EE24C8-B60F-4B6C-A14A-2F2023405E05Q38877585-43DA4CB7-1671-497C-9DB3-1F260A84D02FQ39658389-585E0803-056A-49BE-94D2-612C84117821Q40851777-807A02E7-B72C-47FD-B594-7018AC4CE1E9Q41810036-4B5AF31E-F030-479F-B613-80981A4A39BEQ42108639-903EA7A7-BC86-4F73-B6C1-DEA691DD7893Q42514802-BD75C0E9-FFC8-4938-B654-4BFB7187E223Q44195848-41CEE7EF-5447-4E93-AF18-39F6B09846A5Q44346648-249FAADA-A480-40E7-A8E9-D36FCAADACC9Q48283351-84DB9DFE-BBD5-49A4-B5CA-43C9D9E6E42BQ50230269-E2C3E528-2332-4700-94EB-C4170E6FB237Q58775143-6DA398AB-C13B-4581-8B92-B6E84B9E4387
P2860
Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@ast
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@en
type
label
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@ast
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@en
prefLabel
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@ast
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@en
P2860
P921
P1433
P1476
Characterization of cannabinoi ...... ship with mu-opioid receptors.
@en
P2093
Elisabeth J Van Bockstaele
Jillian L Scavone
P2860
P356
10.1016/J.BRAINRES.2009.11.023
P407
P50
P577
2009-11-18T00:00:00Z